€56.75
0.26% today
Madrid, Jul 29, 10:15 am CET
ISIN
ES0157261019
Symbol
ROVI
Index

Laboratorios Farmaceuticos Target price 2025 - Analyst rating & recommendation

Laboratorios Farmaceuticos Classifications & Recommendation:

Buy
73%
Hold
27%

Laboratorios Farmaceuticos Price Target

Target Price €79.15
Price €56.90
Potential
Number of Estimates 11
11 Analysts have issued a price target Laboratorios Farmaceuticos 2026 . The average Laboratorios Farmaceuticos target price is €79.15. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 15 analysts: 11 Analysts recommend Laboratorios Farmaceuticos to buy, 4 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Laboratorios Farmaceuticos stock has an average upside potential 2026 of . Most analysts recommend the Laboratorios Farmaceuticos stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Million € 763.75 739.83
7.93% 3.13%
EBITDA Margin 27.18% 26.84%
7.83% 1.24%

10 Analysts have issued a sales forecast Laboratorios Farmaceuticos 2025 . The average Laboratorios Farmaceuticos sales estimate is

€740m
Unlock
. This is
1.22% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€789m 5.28%
Unlock
, the lowest is
€693m 7.50%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 €764m 7.93%
2025
€740m 3.13%
Unlock
2026
€848m 14.67%
Unlock
2027
€969m 14.22%
Unlock
2028
€986m 1.71%
Unlock
2029
€1.0b 5.22%
Unlock

10 Analysts have issued an Laboratorios Farmaceuticos EBITDA forecast 2025. The average Laboratorios Farmaceuticos EBITDA estimate is

€199m
Unlock
. This is
2.35% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€231m 13.52%
Unlock
, the lowest is
€167m 18.06%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 €208m 15.14%
2025
€199m 4.34%
Unlock
2026
€252m 26.81%
Unlock
2027
€301m 19.53%
Unlock
2028
€364m 20.96%
Unlock
2029
€377m 3.42%
Unlock

EBITDA Margin

2024 27.18% 7.83%
2025
26.84% 1.24%
Unlock
2026
29.68% 10.58%
Unlock
2027
31.06% 4.65%
Unlock
2028
36.94% 18.93%
Unlock
2029
36.31% 1.71%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share 2.67 2.54
16.56% 4.87%
P/E 21.84

10 Analysts have issued a Laboratorios Farmaceuticos forecast for earnings per share. The average Laboratorios Farmaceuticos EPS is

€2.54
Unlock
. This is
3.05% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
€3.00 14.50%
Unlock
, the lowest is
€2.01 23.28%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 €2.67 16.56%
2025
€2.54 4.87%
Unlock
2026
€3.28 29.13%
Unlock
2027
€4.33 32.01%
Unlock
2028
€4.82 11.32%
Unlock

P/E ratio

Current 21.20 1.74%
2025
21.84 3.01%
Unlock
2026
16.92 22.53%
Unlock
2027
12.84 24.11%
Unlock
2028
11.52 10.28%
Unlock

Current Laboratorios Farmaceuticos Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
ODDO BHF
Locked
Locked
Locked Jul 16 2025
BANCO SANTANDER
Locked
Locked
Locked Jul 16 2025
CAIXABANK BPI
Locked
Locked
Locked Jun 29 2025
ALANTRA EQUITIES
Locked
Locked
Locked Jun 18 2025
ANALISIS BANCO SABADELL
Locked
Locked
Locked Jun 12 2025
JEFFERIES
Locked
Locked
Locked Jun 05 2025
JEFFERIES
Locked
Locked
Locked Apr 07 2025
Analyst Rating Date
Locked
ODDO BHF:
Locked
Locked
Jul 16 2025
Locked
BANCO SANTANDER:
Locked
Locked
Jul 16 2025
Locked
CAIXABANK BPI:
Locked
Locked
Jun 29 2025
Locked
ALANTRA EQUITIES:
Locked
Locked
Jun 18 2025
Locked
ANALISIS BANCO SABADELL:
Locked
Locked
Jun 12 2025
Locked
JEFFERIES:
Locked
Locked
Jun 05 2025
Locked
JEFFERIES:
Locked
Locked
Apr 07 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today